STOCK TITAN

Takeda Pharmaceutical Company Limited (TAK) Revenue by Year

TAK

Takeda Pharmaceutical Company Limited generated $30.6B in revenue in fiscal year 2025. This represents an increase of 8.4% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Takeda Pharmaceutical Company Limited has filed alongside them.

FY2025 annual
Revenue $30.6B
YoY +8.4%
5Y CAGR 0.0%
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Mar 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TAK Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-F
Revenue$30.6B+8.4%$28.2B-7.1%$30.3B+3.2%$29.4B+1.7%$28.9B-5.5%$30.6B+61.5%$18.9B+13.7%$16.7B+7.2%$15.5B

TAK Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2320-FQ4'2220-FQ4'2120-FQ4'2020-FQ4'1920-FQ4'1820-F
RevenueN/AN/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Takeda Pharmaceutical Company Limited financials

Frequently Asked Questions

What was Takeda Pharmaceutical Company Limited's revenue in fiscal year 2025?

Takeda Pharmaceutical Company Limited generated $30.6B in revenue in fiscal year 2025.

How fast is Takeda Pharmaceutical Company Limited's revenue growing?

Takeda Pharmaceutical Company Limited (TAK) revenue rose by 8.4% year over year, from $28.2B to $30.6B in fiscal year 2025.

How has Takeda Pharmaceutical Company Limited's revenue changed over the years?

Across the 9 fiscal years this page covers, Takeda Pharmaceutical Company Limited (TAK) revenue went from $15.5B in fiscal year 2017 to $30.6B in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Takeda Pharmaceutical Company Limited (TAK) reported on that line in every period on record.